Neva is pleased to unveil further opportunities as a true collaborator for early-stage pharma/biotech innovators.
LONGMONT, CO, UNITED STATES, February 26, 2026 /EINPresswire.com/ — Having established itself as a distinctive CDMO supporter of the pharma/biotech innovation community (July2025), Neva is pleased to unveil further opportunities as a true collaborator for early-stage pharma/biotech innovators.
In addition to continuing to provide its standard CDMO services, Neva now welcomes queries about how we may be able to help with the various unique challenges encountered by early-stage pharma/biotech innovators.
As Timothy Joy, Neva’s Chairperson and COO points out “expert consultants sitting somewhere and jumping on a call or writing a report to provide you with guidance and support are easy to find. But how many of them can get off a call, and promptly walk into their own lab to test out your theories or produce submission quality data to bolster your IP and move your project forward?”
“Similarly, well-equipped CDMOs are also easy to find and are more than ready to do what you tell them to do – if it fits. But how many can or will guide you with expertise, recommendations or external oversight when what you need is beyond their own internal capabilities or business interests?”
“Finally, how many of those service providers will ever suggest temporarily relocating some of your own unique equipment and/or experts to their facility to physically collaborate, face-to-face with some of the industry’s leading hands-on experts in bioprocessing and testing?”
Neva enjoys considering a variety of support and collaboration tactics which are almost as groundbreaking in the pharma/biotech contract services world as the medicinal products themselves that innovators are trying to advance in human healthcare.
Contact Neva today to inquire about its adaptive, responsive and scale-friendly service approaches and how it can effectively support your product and process development, from early research development stages through commercialization.
About Neva Analytics LLC
Founded in 2017, Neva is an FDA-inspected laboratory providing both GMP and R&D expert services to the pharmaceutical, biotechnology, medical device and allied industries. Neva was founded to provide comprehensive services to companies developing and commercializing healthcare products and has now served clients across North America, Europe and Asia. Neva provides an experienced integrated team for comprehensive analytical and process engineering services. These include analytical activities such as method development and validation, lot release and stability testing, stability study management, product characterization and in-use studies – as well as process development and research, including lead candidate selection, IND enabling or early-phase 1 GMP processing.
For more information about Neva and how we can help you, please visit http://www.nevaanalytics.com or contact us directly at info@nevaanalytics.com.
Timothy Joy
Neva Analytics LLC
+1 303-709-4316
info@nevaanalytics.com
Visit us on social media:
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
